CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-25 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −158 | $34.32 | $5K | 78,795 |
| 2022-11-25 | Sturmer Michael E PRESIDENT | Shares withheld for taxes | −6,437 | $34.32 | $221K | 210,320 |
| 2022-11-23 | Payson Norman Director | Sale | −6,617 | $34.25 | $227K | 298,914 |
| 2022-11-22 | Payson Norman Director | Sale | −6,617 | $33.80 | $224K | 305,531 |
| 2022-11-10 | Payson Norman Director | Sale | −4,617 | $37.79 | $174K | 314,148 |
| 2022-11-10 | Payson Norman Director | Sale | −1,900 | $38.96 | $74K | 312,248 |
| 2022-11-10 | Payson Norman Director | Sale | −100 | $39.84 | $4K | 312,148 |
| 2022-11-09 | Payson Norman Director | Sale | −4,417 | $37.54 | $166K | 320,965 |
| 2022-11-09 | Payson Norman Director | Sale | −1,300 | $38.58 | $50K | 319,665 |
| 2022-11-09 | Payson Norman Director | Sale | −900 | $39.55 | $36K | 318,765 |
| 2022-11-07 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +25,905 | $3.95 | $102K | 276,350 |
| 2022-11-07 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −9,438 | $39.95 | $377K | 266,912 |
| 2022-11-07 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −16,307 | $40.58 | $662K | 250,605 |
| 2022-11-07 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −160 | $41.41 | $7K | 250,445 |
| 2022-11-07 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −2,359 | $39.95 | $94K | 160,715 |
| 2022-11-07 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −4,077 | $40.58 | $165K | 156,638 |
| 2022-11-07 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −40 | $41.41 | $2K | 156,598 |
| 2022-11-07 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −25,905 | 1,355,555 | ||
| 2022-11-07 | Schlanger David J Executive Chairman | Exercise or conversion | +8,146 | $0.91 | $7K | 90,694 |
| 2022-11-07 | Schlanger David J Executive Chairman | Sale | −3,072 | $39.87 | $122K | 87,622 |
Page 34 of 77 · 1,524 trades